[6-[[(3aS,7R,7aS)-7-hydroxy-4-oxo-1,3a,5,6,7,7a-hexahydroimidazo[4,5-c]pyridin-2-yl]amino]-5-[[(3S)-3-acetamido-6-[[(3S)-3-amino-6-[[(4S)-4,7-diamino-2-oxoheptyl]amino]hexanoyl]amino]hexanoyl]amino]-3,4-dihydroxyoxan-2-yl]methyl carbamate
| Internal ID | f642ed3e-9080-4c52-ba45-262e83f21f23 |
| Taxonomy | Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Glycosyl compounds > Glycosylamines |
| IUPAC Name | [6-[[(3aS,7R,7aS)-7-hydroxy-4-oxo-1,3a,5,6,7,7a-hexahydroimidazo[4,5-c]pyridin-2-yl]amino]-5-[[(3S)-3-acetamido-6-[[(3S)-3-amino-6-[[(4S)-4,7-diamino-2-oxoheptyl]amino]hexanoyl]amino]hexanoyl]amino]-3,4-dihydroxyoxan-2-yl]methyl carbamate |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C34H62N12O11/c1-17(47)42-20(7-4-10-40-24(50)12-19(37)6-3-9-39-14-21(48)11-18(36)5-2-8-35)13-25(51)43-28-30(53)29(52)23(16-56-33(38)55)57-32(28)46-34-44-26-22(49)15-41-31(54)27(26)45-34/h18-20,22-23,26-30,32,39,49,52-53H,2-16,35-37H2,1H3,(H2,38,55)(H,40,50)(H,41,54)(H,42,47)(H,43,51)(H2,44,45,46)/t18-,19-,20-,22+,23?,26+,27-,28?,29?,30?,32?/m0/s1 |
| InChI Key | SBZZIAKATIBEOF-ICFBGCGWSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C34H62N12O11 |
| Molecular Weight | 814.90 g/mol |
| Exact Mass | 814.46610084 g/mol |
| Topological Polar Surface Area (TPSA) | 382.00 Ų |
| XlogP | -7.60 |
| Atomic LogP (AlogP) | -6.31 |
| H-Bond Acceptor | 18 |
| H-Bond Donor | 14 |
| Rotatable Bonds | 24 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.5255 | 52.55% |
| Caco-2 | - | 0.8633 | 86.33% |
| Blood Brain Barrier | - | 0.7750 | 77.50% |
| Human oral bioavailability | - | 0.5143 | 51.43% |
| Subcellular localzation | Mitochondria | 0.4036 | 40.36% |
| OATP2B1 inhibitior | - | 0.8609 | 86.09% |
| OATP1B1 inhibitior | + | 0.8305 | 83.05% |
| OATP1B3 inhibitior | + | 0.9402 | 94.02% |
| MATE1 inhibitior | - | 0.8600 | 86.00% |
| OCT2 inhibitior | - | 0.7000 | 70.00% |
| BSEP inhibitior | + | 0.8108 | 81.08% |
| P-glycoprotein inhibitior | + | 0.7355 | 73.55% |
| P-glycoprotein substrate | + | 0.8294 | 82.94% |
| CYP3A4 substrate | + | 0.7259 | 72.59% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8216 | 82.16% |
| CYP3A4 inhibition | - | 0.9397 | 93.97% |
| CYP2C9 inhibition | - | 0.8904 | 89.04% |
| CYP2C19 inhibition | - | 0.8737 | 87.37% |
| CYP2D6 inhibition | - | 0.8967 | 89.67% |
| CYP1A2 inhibition | - | 0.8646 | 86.46% |
| CYP2C8 inhibition | + | 0.7139 | 71.39% |
| CYP inhibitory promiscuity | - | 0.9785 | 97.85% |
| UGT catelyzed | + | 0.8000 | 80.00% |
| Carcinogenicity (binary) | - | 0.9500 | 95.00% |
| Carcinogenicity (trinary) | Non-required | 0.5840 | 58.40% |
| Eye corrosion | - | 0.9842 | 98.42% |
| Eye irritation | - | 0.9018 | 90.18% |
| Skin irritation | - | 0.7610 | 76.10% |
| Skin corrosion | - | 0.9220 | 92.20% |
| Ames mutagenesis | - | 0.5500 | 55.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.4574 | 45.74% |
| Micronuclear | + | 0.8000 | 80.00% |
| Hepatotoxicity | - | 0.6101 | 61.01% |
| skin sensitisation | - | 0.8234 | 82.34% |
| Respiratory toxicity | + | 0.8111 | 81.11% |
| Reproductive toxicity | + | 0.9444 | 94.44% |
| Mitochondrial toxicity | + | 0.8375 | 83.75% |
| Nephrotoxicity | - | 0.6615 | 66.15% |
| Acute Oral Toxicity (c) | III | 0.5322 | 53.22% |
| Estrogen receptor binding | + | 0.7997 | 79.97% |
| Androgen receptor binding | + | 0.6388 | 63.88% |
| Thyroid receptor binding | + | 0.5170 | 51.70% |
| Glucocorticoid receptor binding | + | 0.5709 | 57.09% |
| Aromatase binding | + | 0.6830 | 68.30% |
| PPAR gamma | + | 0.7076 | 70.76% |
| Honey bee toxicity | - | 0.7110 | 71.10% |
| Biodegradation | - | 0.6500 | 65.00% |
| Crustacea aquatic toxicity | - | 0.5800 | 58.00% |
| Fish aquatic toxicity | - | 0.7476 | 74.76% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.80% | 83.82% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.63% | 91.11% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.22% | 96.09% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 97.68% | 94.45% |
| CHEMBL2581 | P07339 | Cathepsin D | 97.18% | 98.95% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 95.64% | 97.09% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 94.91% | 99.17% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 94.64% | 90.08% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 93.16% | 96.90% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 93.07% | 96.28% |
| CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 92.93% | 89.34% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 91.73% | 98.05% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 91.73% | 98.33% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 90.89% | 95.71% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 90.78% | 99.23% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 90.29% | 97.21% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 89.44% | 89.50% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 88.96% | 100.00% |
| CHEMBL3401 | O75469 | Pregnane X receptor | 87.73% | 94.73% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 87.30% | 93.10% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 86.97% | 82.86% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 86.94% | 97.79% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 86.66% | 94.33% |
| CHEMBL4630 | O14757 | Serine/threonine-protein kinase Chk1 | 86.50% | 97.03% |
| CHEMBL2345 | P51812 | Ribosomal protein S6 kinase alpha 3 | 86.31% | 95.64% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 85.68% | 90.71% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 85.24% | 96.21% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 85.20% | 95.00% |
| CHEMBL5852 | Q96P65 | Pyroglutamylated RFamide peptide receptor | 83.59% | 85.00% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 82.44% | 95.50% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 82.04% | 92.32% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 81.61% | 98.59% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 81.42% | 88.56% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 81.13% | 94.00% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 80.65% | 95.50% |
| CHEMBL1075162 | Q13304 | Uracil nucleotide/cysteinyl leukotriene receptor | 80.19% | 80.33% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 163188363 |
| LOTUS | LTS0233053 |
| wikiData | Q105249818 |